<DOC>
	<DOC>NCT00560235</DOC>
	<brief_summary>Define the efficacy of CP-751,871 in patients with Ewing's sarcoma family of tumors</brief_summary>
	<brief_title>Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors</brief_title>
	<detailed_description />
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Sarcoma, Ewing</mesh_term>
	<mesh_term>Antibodies, Monoclonal</mesh_term>
	<criteria>Ewing's family of tumors Current disease state for which there is no curative therapy Prior antiIGF1R therapy Concurrent treatment with other anticancer agents</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>